Belite Bio to present Phase 3 DRAGON topline results for tinlarebant
The company said the topline readout in adolescent Stargardt disease is scheduled for Oct. 4, 2026, at Euretina in Vienna.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.